###### Strengths and limitations of this study

-   Chronic obstructive pulmonary disease (COPD) is largely managed in primary care and our study uses high-quality routine primary care data for all patients with COPD diagnosed in primary care in participating general practices, and therefore reflects the characteristics of patients in the population with COPD.

-   The primary care data were enriched through linkage to secondary care admissions data, death data, cancer registrations and a spirometry database to establish a novel comprehensive pseudonymised data set with over 25 000 person years of follow-up.

-   We identified separate risk factors for first and subsequent admissions after primary care diagnosis which helps to explain the conflicting results observed in other studies that have not differentiated between first and subsequent admissions.

-   Using routine data does have some limitations such as dealing with missing data; however, sensitivity analyses were carried out to check the effect of missing primary care data.

-   It was not possible to investigate variables that are not recorded routinely, such as support from carers and family members, which may affect admission risk.

Introduction {#s1}
============

Hospital admission for chronic obstructive pulmonary disease (COPD) is a significant burden on healthcare resources and readmission rates are high. COPD is the second most common reason for emergency hospital admission in the UK. Acute exacerbations of COPD (AECOPD) are responsible for the majority of the disease burden,[@R1] contribute to the progressive decline in lung function[@R2] and reduce patients' quality of life.[@R3] Although patients with very severe exacerbations may need to be admitted to hospital, COPD admissions are considered to be 'potentially preventable'. In recent years, there has been a policy emphasis on shifting the balance of care for long-term conditions from secondary to primary care. Reducing hospital admission rates for 'ambulatory care sensitive' conditions, such as COPD, is one of the main goals of this policy shift.

There is considerable inconsistency in the literature regarding patient characteristics associated with risk of AECOPD hospital admission and readmission.[@R4] These inconsistencies result from differences in study design used, confounders adjusted for and the population studied. Evidence from primary care populations is scarce. Primary care-based studies have not distinguished between first and subsequent admissions after diagnosis,[@R5] or have looked at first admission and death as a joint outcome.[@R6] Studies that have distinguished between a first admission[@R7] and a readmission[@R8] [@R9] have used hospital-based populations. In some studies, patients were predominantly men.[@R5] [@R7] [@R10] These hospital-based studies may not be representative of the wider COPD population.

As COPD is now managed predominantly in primary care, we aimed to investigate patient characteristics associated with risk of first AECOPD hospital admission and readmission, after primary care COPD diagnosis, in a representative primary care patient population. Our ability to link electronic primary care data pseudonymously to high-quality routine admissions data made this possible.

Methods {#s2}
=======

Primary care COPD cohort {#s2a}
------------------------

Primary care general practices in the Lothian Health Board area of Scotland (population approximately 800 000) that used General Practice Administration System for Scotland (GPASS) software to hold patient data were invited to participate in the study. Data were extracted from 72 of 103 eligible practices by remote electronic access. Patients were included in the cohort if they had a diagnostic Read code for COPD first recorded in their electronic health record between 1 April 2000 and 31 March 2008. Date of first recorded COPD Read code in primary care was used as a proxy for date of diagnosis (see online [supplementary appendix](http://bmjopen.bmj.com/lookup/suppl/doi:10.1136/bmjopen-2015-009121/-/DC1) table A1). Patients were excluded if they were under 35 years of age at date of diagnosis. Patients were followed up until they left a participating practice, death or 31 March 2010, whichever was sooner. Primary care clinical data were separated from patient identifiable data to protect patient confidentiality during linkage and analysis; both data sets retained a unique pseudonymised ID to enable linkage.

Linked data set {#s2b}
---------------

The data linkage team at the Information Services Division (ISD) of National Health Service (NHS) National Services Scotland (NHS NSS) used the unique Community Health Index (CHI) number to link primary care patients to the national Acute Cancer Deaths and Mental Health (ACaDMe) linked data set. The ACaDMe data set contains hospital admissions (Scottish morbidity record; SMR01), cancer registrations (SMR06) and death data (National Records of Scotland; NRS). International Classification of Diseases (ICD) 9 and ICD10 codes for relevant hospital admissions (AECOPD, COPD and comorbidities) are specified in the online [supplementary appendix](http://bmjopen.bmj.com/lookup/suppl/doi:10.1136/bmjopen-2015-009121/-/DC1) table A2.

Additional spirometry and smoking data were extracted from a hospital spirometry database (Royal Infirmary and Western General Hospitals, Edinburgh). This data set was linked to the primary care data set using probability matching of patient identifiable variables (name, sex, date of birth, postcode, CHI number).

Specificity and sensitivity for the linkage methods used by ISD are thought to be close to 100% when full identifiers are present (name, date of birth, sex, postcode, CHI). Even when limited identifiers have been used (date of birth, sex, postcode) up to 98.1% precision and 99.5% sensitivity in linkage has been achieved (C Morris, personal communication, 2015).

Deprivation was assessed using the Scottish Index of Multiple Deprivation 2009 (SIMD2009), an area-based measure. Lothian deprivation quintiles were determined from patients' postcodes.

Patient identifiable data were removed to create a pseudonymised linked database that was released to the research team for analysis.

Patient characteristics {#s2c}
-----------------------

Patient characteristics investigated were age at diagnosis, sex, deprivation, disease severity (based on Global Initiative for Chronic Obstructive Lung Disease (GOLD) category),[@R11] body mass index (BMI), smoking status, asthma, other respiratory comorbidities (history of pneumonia, respiratory failure, cor pulmonale), non-respiratory comorbidity (cancer, chronic kidney disease, liver disease, dementia, depression, coronary heart disease, heart failure, stroke, hypertension, diabetes and osteoporosis), prior COPD interventions and prior COPD admissions (prior to diagnosis in primary care; see online [supplementary appendix](http://bmjopen.bmj.com/lookup/suppl/doi:10.1136/bmjopen-2015-009121/-/DC1) tables A1--A3), and travel time to hospital. Baseline was defined as date of COPD diagnosis in primary care records; closest measurements to baseline were used in the analysis with the exception of deprivation and travel time to hospital which were based on most recent patient postcode recorded. Baseline measurements were used to reduce the risk of introducing immortal time bias. Categorical variables were described by the number and percentage of patients in each category. Continuous variables were described by the mean and SD.

We acknowledged that some patients have had a COPD admission (see online [supplementary appendix](http://bmjopen.bmj.com/lookup/suppl/doi:10.1136/bmjopen-2015-009121/-/DC1) table A2) prior to diagnosis in primary care. As this may reflect a delay in diagnosis, this was explored as an independent risk factor for admission after diagnosis. The results of this study, therefore, should be interpreted as risks for first AECOPD admission and readmission after primary care diagnosis.

Outcomes {#s2d}
--------

Primary outcomes were first and subsequent AECOPD hospital admissions after primary care diagnosis date (ICD10 codes J44.0, J44.1 in any diagnostic position). Median follow-up time was calculated using the reverse Kaplan-Meier estimate.[@R12]

Patients were at risk of readmission from date of discharge of previous AECOPD admission. Admissions occurring within 14 days of discharge from previous AECOPD admission were excluded. Secondary outcomes were general practitioner (GP)-treated exacerbations (see online [supplementary appendix](http://bmjopen.bmj.com/lookup/suppl/doi:10.1136/bmjopen-2015-009121/-/DC1) table A3) and death.

First AECOPD hospital admission {#s2e}
-------------------------------

Kaplan-Meier[@R13] survival curves and log-rank tests were used for univariate analysis of association of baseline patient characteristics with time to first hospital admission for AECOPD (data not shown).

Time to first AECOPD hospital admission from date of diagnosis in primary care was analysed using a Cox proportional hazards regression model.[@R14] Variables for the model were identified on the basis of results of univariate analysis and a priori knowledge. Baseline characteristics ([table 1](#BMJOPEN2015009121TB1){ref-type="table"}) were entered into the model and were categorical except for age, which was continuous and standardised. The proportional hazards assumption was evaluated for each variable by visual inspection of the log-minus-log plots across the covariate categories and by analysing residuals.

###### 

Baseline characteristics for patients in cohort

  Characteristic at diagnosis of COPD in primary care    Cohort (n=7002)   
  ------------------------------------------------------ ----------------- ------
  Sex                                                                      
   Male                                                  3585              51.2
  Deprivation                                                              
   Quintile 1 (most deprived)                            2199              31.4
   Quintile 2                                            1789              25.5
   Quintile 3                                            1367              19.5
   Quintile 4                                            999               14.3
   Quintile 5 (least deprived)                           648               9.3
  COPD severity (% predicted forced expiratory volume)                     
   Mild (≥80)                                            781               11.2
   Moderate (≥50 and \<80)                               3203              45.7
   Severe (≥30 and \<50)                                 1516              21.7
   Very severe (\<30)                                    357               5.1
   Unknown                                               1145              16.4
  Body mass index (kg/m^2^)                                                
   Low (≥12 and \<20)                                    754               10.8
   Normal (≥20 and \<25)                                 1894              27.0
   High (≥25)                                            3106              44.4
   Unknown                                               1248              17.8
  Smoking status                                                           
   Current smoker                                        4003              57.2
   Not current smoker                                    2431              34.7
   Never smoked                                          274               3.9
   Unknown                                               294               4.2
  Asthma comorbidity                                     1061              15.2
  Other respiratory comorbidity                          530               7.6
  Non-respiratory comorbidity                            2524              36.0
  Prior admission with COPD                              1482              21.2
  Prior intervention for COPD                            3469              49.5

COPD, chronic obstructive pulmonary disease.

AECOPD readmission {#s2f}
------------------

AECOPD readmissions were modelled using a Prentice-Williams-Peterson (PWP) recurrent event model, an extension of Cox regression which conditions on the occurrence of the preceding event in the analysis of each recurrent event.[@R15] For up to 10 AECOPD admissions per patient (only 34 patients had 11 or more admissions), we modelled associations between each covariate and first AECOPD admission/readmissions. Likelihood ratio tests showed that associations were similar across admissions 2--10 but differed for first admissions (data not shown). A PWP model was, therefore, fitted to data for AECOPD admissions 2--10, for which the reporting of the common HR would be meaningful. The proportional hazards assumption was evaluated for each variable by visual inspection of the Kaplan-Meier curves across the covariate categories. The assumption of linearity for age was also tested.

Missing data {#s2g}
------------

A small number of patients (69, 1%) were missing postcode and hence deprivation quintile; these individuals were omitted from modelling of outcomes.

Exploratory analysis indicated that missing COPD severity, BMI and smoking status could not be assumed to be missing completely at random; 'missing' was therefore retained as a separate category for modelling.

Sensitivity analysis {#s2h}
--------------------

A sensitivity analysis for time to first AECOPD admission excluded patients with missing COPD severity, BMI and smoking status. To account for practice clustering, we fitted a term for clustering fitted as a random effect (frailty term) in the Cox proportional hazards model.

Statistical software {#s2i}
--------------------

Data were analysed using IBM SPSS Statistics for Windows V.20, R for Windows V.2.13.1 and SAS System for Windows V.9.3 (SAS Institute Inc, Cary, North Carolina, USA).

Results {#s3}
=======

Patient characteristics {#s3a}
-----------------------

[Table 1](#BMJOPEN2015009121TB1){ref-type="table"} shows baseline characteristics of the patients in the cohort (n=7002). The mean age at diagnosis was 67.1 years (SD 11.4); there were similar numbers of men and women and over half of the patients (57%) were resident in the two most deprived quintiles in Lothian (quintiles 1 and 2). A high proportion of the patients (67%) had at least one comorbidity at time of diagnosis. Almost half (49%) had received treatment for COPD prior to diagnosis in primary care and 21% had a hospital admission where COPD had been recorded prior to diagnosis in primary care. Mean per cent predicted forced expiratory volume in 1 s (FEV~1~) was 59% (SD 18.8) and mean BMI was 26.3 kg/m^2^ (SD 6.1).

The median follow-up time for the cohort was 4.5 years (95% CI 4.3 to 4.6). The event rate was 126.6 (95% CI 122.7 to 130.7) per 1000 patient years for all AECOPD admissions after primary care diagnosis ([table 2](#BMJOPEN2015009121TB2){ref-type="table"}).

###### 

Summary of outcomes, follow-up and event rates for patients in the cohort

  Outcome                                            Number (%) of patients with outcome   Events   Follow-up   Event rate per 1000 person years (95% CI)             
  -------------------------------------------------- ------------------------------------- -------- ----------- ------------------------------------------- --------- ------------------------
  First admission for AECOPD                         1756 (25.1)                           1756     NA          4.5 (4.3 to 4.6)                            27377.8   64.1 (61.2 to 67.2)
  All admissions for AECOPD†                         1756 (25.1)                           3937     1--31       4.5 (4.3 to 4.6)                            31088.9   126.6 (122.7 to 130.7)
  Readmission within 14 days of previous discharge   235 (3.4)                             448      1--25                                                             
  Death                                              1820 (26.0)                           1820     NA          5.1 (5.0 to 5.2)                            31088.9   58.5 (55.9 to 61.3)
  GP-treated AECOPD‡                                 2718 (38.8)                           10 399   1--48       5.2 (5.1 to 5.4)                            31088.9   334.5 (328.1 to 341.0)

\*Estimation of median follow-up time using the reverse Kaplan-Meier method.

†Readmissions for AECOPD occurring within 14 days of discharge from a previous AECOPD admission were not considered to be new admissions and were not included in the modelling.

‡GP-treated exacerbation defined as prescriptions of antibiotics (amoxicillin, cefalexin, ciprofloxacin, clarithromycin, co-amoxiclav, doxycycline or erythromycin) and oral prednisolone within 7 days of each other and more than 21 days since a previous prescription.

AECOPD, acute exacerbation of chronic obstructive pulmonary disease; GP, general practitioner; NA, not applicable.

First AECOPD admission after diagnosis {#s3b}
--------------------------------------

In total, 1756 patients (25%) had at least one AECOPD admission. Nine hundred and fifty-five (14%) patients were censored due to death, 958 (14%) patients were censored due to leaving a participating general practice and 3333 (48%) were censored at the end of study.

[Table 3](#BMJOPEN2015009121TB3){ref-type="table"} presents the unadjusted and fully adjusted modelling of time to first AECOPD admission. Older age, increasing disease severity (or unknown severity), low BMI (or unknown BMI), current smoking, comorbidity (excluding asthma), prior intervention for COPD and prior COPD admission were all associated with an increased risk of first AECOPD admission after diagnosis in the adjusted model. Decreasing deprivation (quintiles 3--5) and high BMI were associated with a reduced risk of first AECOPD admission in the adjusted model. We did not find a significant association between travel time to hospital and risk of AECOPD admission (data not shown).

###### 

Associations between patient characteristics at diagnosis of COPD in primary care and time to first hospital admission for acute exacerbation of COPD

  Characteristic at diagnosis of COPD in primary care    Level                           Risk of first admission                                               
  ------------------------------------------------------ ------------------------------- ------------------------- --------------------- --------------------- ----------
  Age (years)                                            Increase of 1 SD (11.4 years)   1.42 (1.35 to 1.49)       \<0.0001              1.31 (1.23 to 1.39)   \<0.0001
  Sex                                                    Female                          1.06 (0.97 to 1.17)       0.21                  0.99 (0.90 to 1.09)   0.82
  Deprivation                                            Quintile 1 (most deprived)      1.00                      0.003                 1.00                  0.0002
  Quintile 2                                             0.96 (0.85 to 1.08)                                       0.89 (0.79 to 1.01)                         
  Quintile 3                                             0.80 (0.70 to 0.92)                                       0.76 (0.66 to 0.87)                         
  Quintile 4                                             0.80 (0.68 to 0.93)                                       0.80 (0.68 to 0.93)                         
  Quintile 5 (least deprived)                            0.84 (0.71 to 1.01)                                       0.74 (0.62 to 0.89)                         
  COPD severity (% predicted forced expiratory volume)   Mild                            1.00                      \<0.0001              1.00                  \<0.0001
  Moderate                                               1.43 (1.17 to 1.75)                                       1.44 (1.18 to 1.76)                         
  Severe                                                 2.89 (2.37 to 3.54)                                       2.44 (1.99 to 2.99)                         
  Very severe                                            4.55 (3.60 to 5.75)                                       3.33 (2.63 to 4.22)                         
  Unknown                                                2.41 (1.93 to 3.01)                                       1.64 (1.30 to 2.06)                         
  Body mass index (kg/m^2^)                              Normal                          1.00                      \<0.0001              1.00                  \<0.0001
  Low                                                    1.61 (1.37 to 1.89)                                       1.47 (1.25 to 1.73)                         
  High                                                   0.79 (0.69 to 0.89)                                       0.83 (0.73 to 0.94)                         
  Unknown                                                2.32 (2.04 to 2.64)                                       2.39 (2.09 to 2.74)                         
  Smoking status                                         Current                         1.00                      0.011                 1.00                  \<0.0001
  Not current                                            1.11 (1.00 to 1.22)                                       0.86 (0.78 to 0.96)                         
  Never smoked                                           0.71 (0.52 to 0.96)                                       0.47 (0.35 to 0.65)                         
  Unknown                                                1.18 (0.89 to 1.55)                                       0.70 (0.52 to 0.94)                         
  Asthma comorbidity                                     1.11 (0.97 to 1.26)             0.12                      1.12 (0.97 to 1.28)   0.11                  
  Other respiratory comorbidity                          2.28 (1.96 to 2.64)             \<0.0001                  1.47 (1.26 to 1.72)   \<0.0001              
  Non-respiratory comorbidity                            1.53 (1.39 to 1.68)             \<0.0001                  1.39 (1.24 to 1.55)   \<0.0001              
  Prior admission with COPD                              2.67 (2.42 to 2.95)             \<0.0001                  1.94 (1.75 to 2.17)   \<0.0001              
  Prior intervention for COPD                            1.38 (1.26 to 1.52)             \<0.0001                  1.22 (1.10 to 1.36)   0.0002                

The HRs are from Cox proportional hazards models for time to admission since diagnosis of COPD in primary care.

\*Adjusted for all variables in the table.

COPD, chronic obstructive pulmonary disease.

Sensitivity analyses excluding patients with missing data for BMI, smoking status or severity showed little impact on the HRs or 95% CIs. Accounting for practice clustering by including a frailty term in the model made little difference to the HRs and 95% CIs (see online supplementary appendix table A4).

Readmission {#s3c}
-----------

There was a high rate of readmission in the cohort: 794 patients (51% of those at risk of further admissions) had at least one readmission (median number of admissions=3; IQR 2--4).

The risk of readmission accelerated with each AECOPD admission ([figure 1](#BMJOPEN2015009121F1){ref-type="fig"}) with progressive shortening of the median time to the next admission ([table 4](#BMJOPEN2015009121TB4){ref-type="table"}).

###### 

Median time to first admission since diagnosis of COPD in primary care or median time to each subsequent admission since start of at risk period after previous admission

  Admission   Median time (months)   95% CI
  ----------- ---------------------- ----------------
  1st         Undefined\*            
  2nd         22.0                   (20.0 to 24.5)
  3rd         8.7                    (7.7 to 10.9)
  4th         7.0                    (5.6 to 9.1)
  5th         5.2                    (4.0 to 6.5)
  6th         4.3                    (3.2 to 6.3)
  7th         3.5                    (2.8 to 4.6)
  8th         2.8                    (2.0 to 4.4)
  9th         1.8                    (1.3 to 3.8)
  10th        1.5                    (1.1 to 4.0)

\*\<50% experience event.

COPD, chronic obstructive pulmonary disease.

![Cumulative risk of successive hospital admission for acute exacerbation of chronic obstructive pulmonary disease (COPD). For first admission, time 0 is the date of primary care COPD diagnosis. For subsequent admissions, time 0 is the date on which the patient was considered to become at risk of readmission, which we have defined as 14 days after the date of discharge of the previous acute exacerbation of COPD admission.](bmjopen2015009121f01){#BMJOPEN2015009121F1}

[Table 5](#BMJOPEN2015009121TB5){ref-type="table"} presents the unadjusted and fully adjusted PWP modelling of time to AECOPD readmission. In general, the HRs were closer to one than in the model for time to first AECOPD admission. Only greater COPD severity (or unknown severity) and COPD hospital admission prior to diagnosis remained statistically significantly associated with an increased risk of AECOPD readmission in the fully adjusted model. High BMI remained significantly associated with a decreased risk of AECOPD readmission.

###### 

Associations between characteristics at diagnosis of COPD in primary care and times to 2nd to 10th hospital admissions for AECOPD

  Characteristic at diagnosis of COPD in primary care    Level                           Risk of readmission (2nd to 10th)\*                                               
  ------------------------------------------------------ ------------------------------- ------------------------------------- --------------------- --------------------- ----------
  Age (years)                                            Increase of 1 SD (11.4 years)   1.02 (0.97 to 1.07)                   0.49                  1.02 (0.97 to 1.08)   0.42
  Sex                                                    Female                          0.95 (0.87 to 1.04)                   0.27                  0.97 (0.89 to 1.07)   0.57
  Deprivation                                            Quintile 1                      1.00                                  0.23                  1.00                  0.27
  Quintile 2                                             0.92 (0.83 to 1.03)                                                   0.94 (0.84 to 1.04)                         
  Quintile 3                                             0.91 (0.80 to 1.04)                                                   0.94 (0.82 to 1.08)                         
  Quintile 4                                             0.94 (0.81 to 1.09)                                                   0.97 (0.84 to 1.13)                         
  Quintile 5                                             0.81 (0.67 to 0.99)                                                   0.80 (0.65 to 0.98)                         
  COPD severity (% predicted forced expiratory volume)   Mild                            1.00                                  \<0.0001              1.00                  \<0.0001
  Moderate                                               1.19 (0.96 to 1.47)                                                   1.19 (0.95 to 1.47)                         
  Severe                                                 1.42 (1.15 to 1.76)                                                   1.39 (1.12 to 1.72)                         
  Very severe                                            1.78 (1.42 to 2.22)                                                   1.75 (1.39 to 2.19)                         
  Unknown                                                1.59 (1.26 to 2.01)                                                   1.44 (1.14 to 1.83)                         
  Body mass index (kg/m^2^)                              Normal                          1.00                                  0.003                 1.00                  0.021
  Low                                                    1.10 (0.94 to 1.29)                                                   1.10 (0.93 to 1.30)                         
  High                                                   0.86 (0.75 to 0.98)                                                   0.87 (0.76 to 0.99)                         
  Unknown                                                1.03 (0.92 to 1.16)                                                   1.01 (0.89 to 1.13)                         
  Smoking status                                         Current                         1.00                                  0.23                  1.00                  0.46
  Not current                                            1.02 (0.93 to 1.12)                                                   0.99 (0.90 to 1.10)                         
  Never smoked                                           0.79 (0.51 to 1.23)                                                   0.78 (0.50 to 1.23)                         
  Unknown                                                1.25 (0.97 to 1.61)                                                   1.17 (0.89 to 1.53)                         
  Asthma comorbidity                                     1.10 (0.98 to 1.23)             0.11                                  1.11 (0.98 to 1.26)   0.087                 
  Other respiratory comorbidity                          1.21 (1.06 to 1.37)             0.004                                 1.12 (0.98 to 1.28)   0.11                  
  Non-respiratory comorbidity                            0.99 (0.90 to 1.09)             0.85                                  0.99 (0.89 to 1.09)   0.79                  
  Prior admission with COPD                              1.34 (1.23 to 1.47)             \<0.0001                              1.32 (1.20 to 1.45)   \<0.0001              
  Prior intervention for COPD                            1.09 (1.00 to 1.19)             0.053                                 1.06 (0.96 to 1.16)   0.23                  

The HRs are from Prentice-Williams-Peterson models for time to admission since start of at risk period for admission with common regression coefficient(s) across the admission strata.

\*Patients were deemed 'at risk' of further AECOPD admission from 14 days after the date of discharge of the Continuous Inpatient Stay in which the previous exacerbation occurred.

†Adjusted for all variables in the table.

AECOPD, acute exacerbation of COPD; COPD, chronic obstructive pulmonary disease.

Discussion {#s4}
==========

In this primary care population, more patient characteristics were associated with risk of first AECOPD admission than readmission, and associations were stronger for a first admission than a readmission. Only COPD admission prior to diagnosis in primary care and increased (or unknown) severity at diagnosis were predictors of both first AECOPD admission and readmission. High BMI was the only modifiable characteristic associated with reduced risk of both first AECOPD admission and readmission. These results suggest that there is greater potential for primary care to prevent or delay the initial admission through appropriate disease management. This highlights the critical role primary care plays in managing patients with COPD. Readmission rates were high and we saw acceleration in readmission risk with successive admissions. Severe exacerbations contribute to decline in lung function.[@R2] However, risk of readmission may also in part be influenced by the patient and/or GP\'s expectation of an admission based on the patient\'s previous admission history.

To the best of our knowledge, this is the first study to compare separately patient characteristics associated with risk of first AECOPD admission and readmission for a representative primary care-based population using patient-level data. The existing evidence base for patient characteristics associated with admission is conflicting, due to different study designs and populations studied. As more emphasis is being placed on managing COPD in the community, it is important to understand the risk factors for the population being managed. This linked database for an unselected primary care cohort of patients with COPD within Lothian is unique within Scotland. The advantage of population-based data is that they reflect the mix of patients in the population and the different patient pathways. The cohort characteristics and hospitalisation rate are similar to other population-based cohorts of patients with COPD.[@R4] [@R16] Our findings should be generalisable to other UK primary care populations.

Using routine data for research has some limitations. Although coding of main condition in SMR data has been shown to be over 90% accurate in Lothian hospitals,[@R17] the accuracy of primary care data is unknown. It is also possible that patients have been coded as having COPD without meeting the spirometric criteria for inclusion on a disease register. These disease register criteria were introduced in 2004 with spirometric confirmation of diagnosis being incentivised. The issue of missing primary care data was problematic in this study. Missing measurements in primary care may reflect poor recording, less intensive management or lack of patient engagement. Smoking status, BMI and per cent predicted FEV~1~ were not missing at random in this cohort. However, residual confounding from missing data (BMI, smoking status or % predicted FEV~1~) is unlikely as the associations persisted after excluding missing data (data not shown).

It was not possible to investigate variables that are not recorded routinely, such as support from carers and family members, which may affect admission risk. Practice, hospital and geographic factors may also influence admission to hospital.[@R18] However, once patient factors were adjusted for, adjustment for practice effects made little difference to our results and travel time to hospital (data not shown) was not associated with risk of admission. Our analysis did not take account of primary care interventions, such as influenza vaccination, that might affect risk of hospital admission for AECOPD. Time-dependent analysis is required to investigate this, to avoid introducing immortal time bias, but this was not possible in the standard PWP model for readmission. In a separate analysis (data not shown), we used a time-dependent Cox model to investigate interventions associated with risk of first AECOPD admission, but as we were unable to adjust fully for confounding by indication, the results were inconclusive. Further work is required to determine whether primary care interventions can reduce the risk of AECOPD admission.

The start of follow-up for our analysis was date of diagnosis in primary care. Almost half of the patients had been treated for respiratory disease prior to this date of diagnosis and one-fifth of the cohort had a COPD admission prior to diagnosis. We included 'COPD admissions before diagnosis' as a variable, rather than exclude these patients, as the aim of this study was to look at characteristics of a 'real-world' primary care population. The definition of an admission for COPD prior to diagnosis was not limited to exacerbations, but also included any COPD diagnostic code, unlike admissions for AECOPD after diagnosis.

In our study, 10% of readmissions occurred within 14 days of previous discharge. However, we did not count these as new readmissions in accordance with published guidance on using hospital records to define new episodes of COPD exacerbations.[@R22]

We found that more severe disease, as defined by the value of % predicted FEV~1~, had the strongest association with increased risk of both first AECOPD admission and readmission. Association between % predicted FEV~1~ and admissions has been shown in other studies,[@R4] [@R6] [@R9] although not all.[@R8] Increasing age has been identified as a risk factor for hospital admission in some studies[@R6] but again not all.[@R5] [@R8] [@R9] We found that older age at diagnosis was associated with an increased risk of first AECOPD admission but not for readmission.

Compared with patients with BMI in the normal range, low BMI was associated with increased risk of first AECOPD admission; whereas high BMI was associated with decreased risk of first AECOPD admission and readmission. Low BMI is recognised as a marker of more severe disease and has been identified as a risk factor in some[@R6] [@R23] but not all studies.[@R5] The 'obesity paradox' whereby patients with COPD with high BMI have better outcomes (lower all cause mortality and reduced hospital readmission) has been seen by others,[@R6] [@R24] particularly for more severe disease.[@R25] However, the mechanisms underlying the apparent benefit of high BMI in COPD have yet to be elucidated.[@R26]

Comorbidities are prevalent in patients with COPD.[@R27] We found that respiratory conditions other than asthma and non-respiratory comorbidities were associated with an increased risk of first admission but not subsequent admission. A previous hospital-based study found respiratory comorbidities to be associated with increased risk of readmission.[@R8] However, other studies, in line with our findings, have not shown an association between comorbidities and risk of COPD readmission.[@R9] [@R28] [@R29]

The association of deprivation with emergency admissions in general has been well documented but not well explained.[@R30] A previous study (not using patient-level data) showed that deprivation was independently associated with COPD admission.[@R18] Why deprivation remains a significant risk factor in our adjusted model for first AECOPD admission should be further explored. It may be evidence of the inverse care law.[@R31] More deprived populations may be less well engaged with primary care; perhaps they seek help later in the disease course, or perhaps they are less likely to get an appointment to be assessed for an acute exacerbation.

In univariate analysis, not currently smoking was associated with an increased risk of first AECOPD admission compared with current smoking. However, once other factors were adjusted for, this association was reversed and patients recorded as not currently smoking had a lower risk of first AECOPD admission compared with current smokers. There was no association with subsequent admissions. There is limited existing evidence for smoking cessation reducing risk of COPD hospitalisation.[@R32] Other studies have found no association between smoking and hospitalisation risk,[@R5] [@R8] or have found decreased risk in smokers, probably due to reverse causality.[@R33]

Other studies have shown that having a previous admission for AECOPD or respiratory disease increased the risk of a subsequent AECOPD admission.[@R6] [@R9] We found that there was not only an increased risk of a readmission after a first AECOPD admission, but also that having a COPD admission prior to diagnosis in primary care was independently associated with an increased risk of both first AECOPD admission and readmission. It is plausible that earlier diagnosis in primary care reduces the risk of AECOPD admission and readmission: patients older at diagnosis, with more severe disease at diagnosis, and who have had admissions or been treated prior to diagnosis had an increased risk of admission in our study. This increased risk could be a reflection of a more prolonged disease course and/or that prompt coding is important for appropriate disease management. COPD is a progressive disease; diagnosis and coding in primary care will vary between patients. However, the Quality and Outcomes Framework (QOF), the UK pay for performance scheme introduced in 2004, should have incentivised timely coding. QOF disease registers are based on diagnostic codes and are required for disease management and GP payment. For patients diagnosed after the introduction of the QOF (data not shown), the proportion of patients with COPD admissions prior to diagnosis was 3% lower, though admission prior to primary care diagnosis was still significantly associated with a risk of first admission (HR 2.25, 95% CI 1.90 to 2.66; p\<0.0001).

The identification of modifiable patient characteristics associated with risk of first AECOPD admission after diagnosis in primary care can help GPs identify those most at risk. Maintaining a healthy BMI, stopping smoking and managing COPD to slow FEV~1~ decline could all delay an admission for AECOPD. Being aware of non-modifiable patient risk factors associated with increased risk of AECOPD admission could also help target patient groups for disease management, for example, those who are older, who have more severe disease at diagnosis, more comorbidities, greater deprivation or admissions before diagnosis. This study also demonstrates the importance of early diagnosis of COPD, that is, before an AECOPD admission and before decline of FEV~1~.

Conclusions {#s5}
===========

While several patient characteristics were associated with the risk of first AECOPD admission after diagnosis, fewer were found to be associated with the risk of readmission for this primary care population. The risk of readmission accelerated with subsequent admission. Prompt diagnosis in primary care may reduce the risk of AECOPD admission and readmission. The study highlights the important role of primary care in preventing or delaying a first AECOPD admission.
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